Cargando…
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2
Novel coronavirus disease 2019 (COVID-19) causes pulmonary and cardiovascular disorders and has become a worldwide emergency. Myocardial injury can be caused by direct or indirect damage, particularly mediated by a cytokine storm, a disordered immune response that can cause myocarditis, abnormal coa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709498/ https://www.ncbi.nlm.nih.gov/pubmed/33299899 http://dx.doi.org/10.1155/2020/8632048 |
_version_ | 1783617762524921856 |
---|---|
author | dos Anjos, Fernanda Simões, Júlia Leão Batista Assmann, Charles Elias Carvalho, Fabiano Barbosa Bagatini, Margarete Dulce |
author_facet | dos Anjos, Fernanda Simões, Júlia Leão Batista Assmann, Charles Elias Carvalho, Fabiano Barbosa Bagatini, Margarete Dulce |
author_sort | dos Anjos, Fernanda |
collection | PubMed |
description | Novel coronavirus disease 2019 (COVID-19) causes pulmonary and cardiovascular disorders and has become a worldwide emergency. Myocardial injury can be caused by direct or indirect damage, particularly mediated by a cytokine storm, a disordered immune response that can cause myocarditis, abnormal coagulation, arrhythmia, acute coronary syndrome, and myocardial infarction. The present review focuses on the mechanisms of this viral infection, cardiac biomarkers, consequences, and the possible therapeutic role of purinergic and adenosinergic signalling systems. In particular, we focus on the interaction of the extracellular nucleotide adenosine triphosphate (ATP) with its receptors P2X1, P2X4, P2X7, P2Y1, and P2Y2 and of adenosine (Ado) with A2A and A3 receptors, as well as their roles in host immune responses. We suggest that receptors of purinergic signalling could be ideal candidates for pharmacological targeting to protect against myocardial injury caused by a cytokine storm in COVID-19, in order to reduce systemic inflammatory damage to cells and tissues, preventing the progression of the disease by modulating the immune response and improving patient quality of life. |
format | Online Article Text |
id | pubmed-7709498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-77094982020-12-08 Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 dos Anjos, Fernanda Simões, Júlia Leão Batista Assmann, Charles Elias Carvalho, Fabiano Barbosa Bagatini, Margarete Dulce J Immunol Res Review Article Novel coronavirus disease 2019 (COVID-19) causes pulmonary and cardiovascular disorders and has become a worldwide emergency. Myocardial injury can be caused by direct or indirect damage, particularly mediated by a cytokine storm, a disordered immune response that can cause myocarditis, abnormal coagulation, arrhythmia, acute coronary syndrome, and myocardial infarction. The present review focuses on the mechanisms of this viral infection, cardiac biomarkers, consequences, and the possible therapeutic role of purinergic and adenosinergic signalling systems. In particular, we focus on the interaction of the extracellular nucleotide adenosine triphosphate (ATP) with its receptors P2X1, P2X4, P2X7, P2Y1, and P2Y2 and of adenosine (Ado) with A2A and A3 receptors, as well as their roles in host immune responses. We suggest that receptors of purinergic signalling could be ideal candidates for pharmacological targeting to protect against myocardial injury caused by a cytokine storm in COVID-19, in order to reduce systemic inflammatory damage to cells and tissues, preventing the progression of the disease by modulating the immune response and improving patient quality of life. Hindawi 2020-12-01 /pmc/articles/PMC7709498/ /pubmed/33299899 http://dx.doi.org/10.1155/2020/8632048 Text en Copyright © 2020 Fernanda dos Anjos et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article dos Anjos, Fernanda Simões, Júlia Leão Batista Assmann, Charles Elias Carvalho, Fabiano Barbosa Bagatini, Margarete Dulce Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 |
title | Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 |
title_full | Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 |
title_fullStr | Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 |
title_full_unstemmed | Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 |
title_short | Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2 |
title_sort | potential therapeutic role of purinergic receptors in cardiovascular disease mediated by sars-cov-2 |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709498/ https://www.ncbi.nlm.nih.gov/pubmed/33299899 http://dx.doi.org/10.1155/2020/8632048 |
work_keys_str_mv | AT dosanjosfernanda potentialtherapeuticroleofpurinergicreceptorsincardiovasculardiseasemediatedbysarscov2 AT simoesjulialeaobatista potentialtherapeuticroleofpurinergicreceptorsincardiovasculardiseasemediatedbysarscov2 AT assmanncharleselias potentialtherapeuticroleofpurinergicreceptorsincardiovasculardiseasemediatedbysarscov2 AT carvalhofabianobarbosa potentialtherapeuticroleofpurinergicreceptorsincardiovasculardiseasemediatedbysarscov2 AT bagatinimargaretedulce potentialtherapeuticroleofpurinergicreceptorsincardiovasculardiseasemediatedbysarscov2 |